Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting

Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting

Saved in:

Bibliographic Details
Main Authors:	I. Ciobotariu, A. Di Stefani, A. Paradisi, L. Di Nardo, K. Peris
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824002246
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cemiplimab Immunotherapy in the Treatment of Cutaneous Squamous Cell Carcinoma
by: Z. Kozéki, et al.
Published: (2024-01-01)

Cemiplimab in the treatment of locally advanced cutaneous squamous cell carcinoma: a case series study
by: M.A. Pradeau, et al.
Published: (2024-01-01)

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
by: Dirk Schadendorf, et al.
Published: (2024-03-01)

Efficacy and safety of cemiplimab in cutaneous squamous cell carcinoma on chronic wounds: A French retrospective study
by: M. Antoszczak, et al.
Published: (2024-12-01)

The Association of Neutrophil Lymphocyte Ratio and Glycemic Markers in Hemodialysis Patients
by: Mustafa Topal
Published: (2023-08-01)

Neutrophil–Lymphocytes Ratio as Potential Early Marker for Alzheimer’s Disease
by: Carlo Cervellati, et al.
Published: (2024-01-01)

Association between Novel Marker (Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Delta Neutrophil Index) and Outcomes in Sudden Cardiac Arrest Patients
by: Sang Il Han, et al.
Published: (2021-01-01)

Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
by: Dongwook Oh, et al.
Published: (2018-01-01)

The treatment of elderly patients with locally advanced or metastatic cutaneous squamous cell carcinoma using Cemiplimab monotherapy or Cemiplimab associated with palliative radiotherapy: A single centre experience from the United Kingdom
by: A. del Carpio Barreda, et al.
Published: (2024-01-01)

Prognostic significance of neutrophil to lymphocyte ratio (NLR) in oral squamous cell carcinoma
by: Dineshkumar Thayalan, et al.
Published: (2024-09-01)

Comment on “Prognostic significance of neutrophil to lymphocyte ratio (NLR) in oral squamous cell carcinoma”
by: Elumalai perumal, et al.
Published: (2024-09-01)

Combination of Cemiplimab and Radiotherapy in Advanced Squamous Cell Carcinoma
by: André Aparício Martins, et al.
Published: (2025-01-01)

A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma
by: Goar Egoryan, et al.
Published: (2024-12-01)

Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in the Patients with Euthyroid Hashimoto's Thyroiditis
by: Hacer Nur RESBER, et al.
Published: (2023-09-01)

Correlation Of Neutrophil Lymphocyte Ratio And Platelet Lymphocyte Ratio With Severity Of COVID-19
by: Fadil Ahmadhia Warman, et al.
Published: (2024-07-01)

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depressed patients with suicidal behavior: A systematic review
by: A Velasco, et al.
Published: (2024-01-01)

A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
by: J. Kaczmar, et al.
Published: (2024-01-01)

The Impact of the Inflammatory Ratios Neutrophil To Lymphocyte Ratio, Monocyte To Lymphocyte Ratio, Platelet To Lymphocyte Ratio on Abdominal Aortic Aneurysm Growth
by: M. Stevanov, et al.
Published: (2024-01-01)

Significance of Baseline and Changes of Tumor Markers and Neutrophil-to-Lymphocyte Ratio in Predicting Overall Survival for Patients with Advanced Pancreatic Adenocarcinoma: A Retrospective Analysis
by: Makoto Kadokura, et al.
Published: (2023-04-01)

The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio and delirium in ischemic stroke patients
by: Pangbo Wang, et al.
Published: (2025-01-01)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients
by: Gysllene M. C. Brito, et al.
Published: (2021-01-01)

Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
by: Teresa Troiani, et al.
Published: (2025-01-01)

The Impact of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Epithelial Ovarian Cancer
by: Samet Kirat, et al.
Published: (2022-12-01)

The Prognostic Role of Pre-Treatment Neutrophil-to-Lymphocyte Ratio in an Asian Cohort of Patients with Oropharyngeal Squamous Cell Carcinoma
by: Isabelle J. H. Jang, et al.
Published: (2024-11-01)

Systematic review and meta-analysis of the association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with periodontitis
by: Saeideh Ghasemi, et al.
Published: (2024-12-01)

Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
by: Jing Yu, et al.
Published: (2024-12-01)

Comparison of NLR (neutrophil/lymphocyte ratio) and PLR (platelet/lymphocyte ratio) as inflammatory markers in 1st episode mania and bipolar mania: A preliminary study
by: Manish K. Goyal, et al.
Published: (2023-04-01)

Real-world data on tolerability and clinical response of cemiplimab in patients with advanced cutaneous squamous cell carcinoma: A retrospective, multicentre cohort study from the Netherlands
by: Maartje W. Rohaan, et al.
Published: (2023-01-01)

Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
by: Chengyang Yu, et al.
Published: (2025-01-01)

The prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer
by: Mustafa Kandaz, et al.
Published: (2025-01-01)

Neutrophil to Lymphocyte Ratio in Epilepsy: A Systematic Review
by: Samaneh Hosseini, et al.
Published: (2022-01-01)

Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis
by: Hande Guclu, et al.
Published: (2015-01-01)

Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer
by: Kana Ohashi, et al.
Published: (2024-01-01)

Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume in patients with diabetic retinopathy
by: Trisha Ghosh, et al.
Published: (2025-01-01)

Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in hypertensive patients: A prospective cross-sectional study
by: Sudha S, et al.
Published: (2025-01-01)

Utility of Neutrophil–lymphocyte Ratio and Platelet–lymphocyte Ratio in Predicting Malignancy in Patients with Small Renal Mass
by: KR Surag, et al.
Published: (2024-11-01)

Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer
by: Fu Ming-Sheng, et al.
Published: (2022-01-01)

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
by: Dirk Schadendorf, et al.
Published: (2020-05-01)

Platelet mass index, systemic immune-inflammation index, and neutrophil-lymphocyte ratio as practical markers in childhood brucellosis
by: Hilal Koyuncu, et al.
Published: (2025-01-01)

The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy
by: Magdalena Krakowska, et al.
Published: (2018-09-01)